A higher mutational rate was found, compared to other cancer types, coupled with 45% positivity to PD1/PDL1 and tumor-infiltrating lymphocytes, whereas primary breast angiosarcomas exhibit a lower PDL1 expression [112]. This evidence concerns the gene CD274 and cancer.